Supernus Pharmaceuticals (SUPN) Q1 2024 Earnings

27FebConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.29
-0.01
0.28
0.56

Details

Expected EPS
0.56
Actual EPS
0.02
Surprise EPS
-0.54
Surprise Percent
+96.43%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.02 per share for Q1 2024.

0 Comments

Share your thoughts